Use of Immersive Virtual Reality and Therapeutic Exercise as Complementary Therapy in Mild to Moderate Parkinson's Disease (InViPark)

NCT07038590 | Completed DMC

• 2 other identifiers: HEALTHYFIT-UVIGO 1/2024IISGS
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This document is intended to provide participant with information about a research study in which the participant is invited to participate. This study was approved by the Research Ethics Committee of \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_. If the participant decide to participate, will receive personalized information from the investigator. Please read this document beforehand, and the investigator will ask you any questions you may have to understand the details. If the participant wish, the participant can take this document, review it with others, and take your time to decide whether or not to participate. Participation in this study is completely voluntary and free of charge. The participant can decide not to participate, participate, or change your mind by withdrawing your consent at any time during the project without giving any explanation. The investigators assure the participant that this decision will not affect any future participation with this research group. What is the purpose of the study? To analyze whether the use of a physical exercise program in immersive virtual environments (video games) has greater positive effects on Parkinson's symptoms than traditional rehabilitation programs. Why is the participant being offered to participate? The participant is invited to participate because the participant is a person diagnosed with Parkinson's and because, within the Open Science policies of the University of Vigo, the Galicia Sur Biomedical Foundation, and the Nóvoa Santos Foundation, where bringing research closer to the reality of patients is emphasized, the investigators have selected the specialized Parkinson's center of which the participant is a member to participate in this study. What does the participation consist of? The participation consists of carrying out 2/3 sessions per week on alternate days of physical exercise, and depending on whether the participant belong to the control or experimental group, the participant will do it regularly or recreated with a video game. The duration of each session will be 15 minutes. Be part of one group or another will depend on chance (like throwing a coin in the air and it comes up Heads or Cross). The total duration of the intervention in both cases is 3 months. During the project, 2 evaluations will be carried out: Initial evaluation and final evaluation. In all of them they will be collected information in relation to their pharmacological treatment linked to the pathology, autonomy functional balance, gait and risk of falls, functional balance, symptoms and disease monitoring and quality of life. Furthermore, in the experimental group the usability and security of the tool will be evaluated immersive virtual reality used. All these assessments will be carried out in your proximity center on the agreed day and time to optimize said process and will have an approximate duration of 30 minutes. What discomforts or inconveniences does the participation have? The participation requires travel to your reference center to carry out the study. This program, like any physical activity or exercise, may involve greater tiredness and/or musculo-articular discomfort due to the type of exercise to which you will be subjected. No relevant adverse effects have been recorded in the use of immersive virtual environments (video games).

Conditions

Parkinson Disease (PD)

Outcome Measures

Primary Outcomes (1)

• Falls

  Risk of falling measured with the Tinneti Test

  From start to end of treatment at 12 weeks

Secondary Outcomes (11)

• Functional Capacity: balance, gait and risk of falls

  From start to end of treatment at 12 weeks

• Functional Capacity: gait function

  From start to end of treatment at 12 weeks

• Functional Capacity: gait function in dual task

  From start to end of treatment at 12 weeks

• Functional Capacity: lower limbs strength

  From start to end of treatment at 12 weeks

• Functional Capacity: upper limbs strength

  From start to end of treatment at 12 weeks

Study Arms (2)

Usual treatment in patient association

ACTIVE COMPARATOR

Patients participate in memory, relaxation, and occupational therapy workshops.

Other: usual treatment patient association

Exergame and virtual reality program + usual treatment

EXPERIMENTAL

Weekly sessions (2) of exergame with virtual reality added to the usual treatment

Other: exergame program with virtual reality; Other: usual treatment patient association

Interventions

exergame program with virtual reality OTHER

Participants who attend a patient association will add to their usual therapies or virtual exercise program to be developed 2 days a week for 3 months.

Exergame and virtual reality program + usual treatment

usual treatment patient association OTHER

Common therapies in patient associations: memory workshops, relaxation, and occupational therapy

Exergame and virtual reality program + usual treatment; Usual treatment in patient association

Eligibility Criteria

• Age: 30 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Suffering from idiopathic PD confirmed by a neurologist.
• Presenting a stage between 1 and 3 on the Hoehn and Yahr scale.
• Being able to move around unaided.
• Absence of dementia with a score on the Mini-Mental State Examination (MMSE) of 18 or higher.
• Being between 30 and 70 years of age.

You may not qualify if:

• Comorbidity that makes physical exercise inadvisable and that prevents all scheduled assessments from being performed.
• Severe visual and/or hearing disturbances that impede the session.
• Having a history of vertigo, seizures, or epileptic seizures.
• Presence of motor fluctuations and/or dyskinesias, gait blockages, or a history of recent falls.
• Be receiving stable dopaminergic treatment without changes in the previous 3 months and with a prior plan not to change it during the duration of the study.
• Be receiving second-line therapy (deep brain stimulation or intraduodenal pump).
• Be participating in another clinical trial.
• Not attend at least 80% of the immersive virtual reality sessions.

Sponsors & Collaborators

• University of Vigo: lead

Study Sites (1)

University of Vigo

Pontevedra, Spain

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD

Study Record Dates

• First Submitted: December 16, 2024
• First Posted: June 26, 2025
• Study Start: September 5, 2024
• Primary Completion: December 10, 2024
• Study Completion: December 15, 2024
• Last Updated: December 3, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)